A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY). Read more about A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).
Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer. Read more about Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer.
Patient-Reported Financial Toxicity Associated with Contemporary Treatment for Localized Prostate Cancer. Read more about Patient-Reported Financial Toxicity Associated with Contemporary Treatment for Localized Prostate Cancer.
The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide? Read more about The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide?
The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. Read more about The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer.
